Medibord Ltd is a BioCity Nottingham–based medical technology company that designs and manufactures patient positioning boards for use in MRI scanners and radiotherapy. Its first product is a radio-translucent, MR-compatible composite developed in response to oncologists' need for greater treatment accuracy, especially for prostate cancer. The product has received positive feedback from UK users. The company plans to expand sales into the Middle East, followed by the United States and European markets. Medibord recently secured a £75,000 investment from the Mobius Life Sciences Fund to support research and development and accelerate market expansion. As part of the funding, Lucy P. Marcus, chairman of the Mobius Life Sciences Fund, will join Medibord's board as a non-executive director.

Total raised

$120M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2010